Correction to: Drugs in R&D 10.1007/s40268-018-0238-8 {#Sec1}
=====================================================

In the original publication of the article, Table 2 has been published incorrectly. The corrected Table [2](#Tab2){ref-type="table"} is shown below:Table 2Signal scores from FAERS (2016Q2): cardiovascular and cerebrovascular eventsEvent\*First-generation PIsIndinavirNelfinavirRitonavirSaquinavir*n*EBGMEB05*n*EBGMEB05*n*EBGMEB05*n*EBGMEB05Carotid artery occlusion10.9660.213NRNRNR31.0570.40511.0210.225**Carotid artery stenosis93.5232.003**21.0970.34741.0080.43610.7650.169Carotid artery thrombosis21.5350.486NRNRNRNRNRNRNRNRNRCoronary artery insufficiency11.230.271NRNRNRNRNRNRNRNRNR**Coronary artery occlusion323.2752.432**101.5170.889351.9751.486**163.1472.063Coronary artery thrombosis**21.3670.43310.6360.1420.6350.201**42.8461.227Coronary artery stenosis**51.9590.922**114.1512.488162.4051.576**41.9980.864Ischemic stroke10.5050.111NRNRNR60.6270.315NRNRNRSudden cardiac deathNRNRNRNRNRNR20.4940.15710.9150.202Ischemic heart disease (SMQ)3731.8021.6532531.851.6674941.161.0771771.8961.673**Myocardial infarction (SMQ)**3251.9121.744**2292.0161.806**4301.221.126**1612.081.824**CNS hemorrhages and cerebrovascular conditions (SMQ)1540.9110.796750.5940.492970.780.708700.8760.717Event\*Second-generation PIsAtazanavirDarunavirFosamprenavirTipranavir*n*EBGMEB05*n*EBGMEB05*n*EBGMEB05*n*EBGMEB05Carotid artery occlusionNRNRNRNRNRNR11.0820.238NRNRNR**Carotid artery stenosis**NRNRNRNRNRNRNRNRNR**32.8291.063**Carotid artery thrombosisNRNRNRNRNRNRNRNRNRNRNRNRCoronary artery insufficiencyNRNRNRNRNRNRNRNRNRNRNRNRCoronary artery occlusion50.5770.27261.1920.59820.860.27210.750.165Coronary artery thrombosis51.9140.901NRNRNRNRNRNRNRNRNR**Coronary artery stenosis102.1891.282**41.7320.74931.7610.675NRNRNRIschemic strokeNRNRNR30.7440.285NRNRNRNRNRNRSudden cardiac death61.9190.96320.9120.289NRNRNRNRNRNRIschemic heart disease (SMQ)1760.8810.7771401.1120.966370.8840.67180.3820.21Myocardial infarction (SMQ)1490.8940.781211.1691.005330.9290.69360.3350.168CNS hemorrhages and cerebrovascular conditions (SMQ)1020.5650.479930.7930.667240.6790.482291.5851.159The threshold for disproportional reporting was *n* ≥ 3, EBGM ≥ 2, and EB05 \> 1. Events that met the disproportionality threshold are in bold*2016Q2* 2016 quarter 2, *CI* confidence interval, *CNS* central nervous system, *FAERS* US Food and Drug Administration Adverse Event Reporting System, *EBGM* Empirical Bayesian Geometric Mean, *EB05* lower bound of the 2-sided 90% CI around EBGM, *MedDRA* Medical Dictionary for Regulatory Activities, *NR* not reported, *PIs* protease inhibitors, *SMQ* Standardized MedDRA Query^\*^Events based on MedDRA preferred terms or SMQs (as noted)
